Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olodaterol dose finding in intermittent asthma
NCT00928668Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jan 2006
- Primary completion
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of olodaterol in asthma, sponsored by Boehringer Ingelheim. Started Jan 2006; status: completed.
02
Drugs
olodaterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00928668.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00928668.